Enhancing Brain And Mental Health Through Breathing Practice
1 other identifier
interventional
40
1 country
2
Brief Summary
The purpose of this study is to evaluate the feasibility of a structured breathing intervention in rural and non-rural adolescents diagnosed with anxiety and depression, recruited from outpatient pediatric and child/adolescent psychiatry clinics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2026
CompletedFirst Posted
Study publicly available on registry
January 27, 2026
CompletedStudy Start
First participant enrolled
February 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
March 4, 2026
March 1, 2026
11 months
January 19, 2026
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Feasibility of Intervention Measure (FIM) score
The Feasibility of Intervention Measure (FIM) is a self-reported questionnaire for participants to rate the feasibility of the breathing practice intervention on a 5-point Likert scale. Possible scores range from 0 (Completely Disagree) to 5 (Completely Agree)
4 months
Acceptability of Intervention Measure (AIM) score
The Acceptability of Intervention Measure (AIM) is a self-reported, 4 question survey, for participants to rate their acceptance of the breathing practice intervention on a 5-point Likert scale. Possible scores range from 0 (Completely Disagree) to 5 (Completely Agree)
4 months
Intervention Appropriateness Measure (IAM) score
The Intervention Appropriateness Measure (IAM) is a self-reported, 4 question survey, for participants to rate the appropriateness of the breathing practice intervention on a 5-point Likert scale. Possible scores range from 0 (Completely Disagree) to 5 (Completely Agree)
4 months
Recruitment feasibility
Proportion of eligible adolescents enrolled out of total participants screened
4 months
Retention feasibility
Proportion of participants retained through final assessment out of total enrolled
4 months
Secondary Outcomes (3)
System Usability Scale (SUS) score
4 months
Total number of log-ins
4 months
Completion rate of assigned breathing practices
4 months
Other Outcomes (2)
Feasibility of collecting physiological data from baseline to 4 months
Baseline to 4 months
Feasibility of collecting psychological data
Baseline to 4 months
Study Arms (1)
Rural adolescent patients
EXPERIMENTALRural and non-rural adolescent patients of Mayo Clinic Health Systems, aged 12 to 17 years, with a clinical diagnosis of mild to moderate anxiety and/or depression will follow a structured breathing practice (Seokmun Hoheup) at least 3 times per week.
Interventions
Participants will follow a structured breathing practice (Seokmun Hoheup) that progresses in incremental steps, beginning with 15 minutes, increasing to 30 minutes, and then to 36 minutes per session over the course of the program.
Eligibility Criteria
You may qualify if:
- Adolescents between the ages of 12 and 17 who have been diagnosed with a major depressive disorder (mild or moderate) and/or an anxiety disorder.
- Participants may have co-occurring mild to moderate alcohol or drug use problems, provided these do not require immediate specialized treatment or crisis intervention.
- All participants must be receiving care at one of two participating MCHS outpatient psychiatry clinics and may reside in rural area (RUCA code 4-10) or non-rural area.
- Participants must be able to read and understand English, and both parental or guardian consent and adolescent assent will be required.
You may not qualify if:
- Current suicidal ideation or self-harm behavior requiring immediate clinical intervention
- Presence of severe psychiatric comorbidities such as psychosis, bipolar disorder, depression with psychotic features, severe alcohol and drug use, or eating disorders.
- Participants with significant cognitive impairment that would interfere with study participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (2)
Mayo Clinic Health System-Albert Lea
Albert Lea, Minnesota, 56007, United States
Mayo Clinic Health System-Eau Claire Clinic
Eau Claire, Wisconsin, 54703, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pravesh Sharma
Mayo Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 19, 2026
First Posted
January 27, 2026
Study Start
February 19, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Last Updated
March 4, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share